Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.52p
   
  • Change Today:
    -0.010p
  • 52 Week High: 7.80p
  • 52 Week Low: 1.45p
  • Currency: UK Pounds
  • Shares Issued: 543.14m
  • Volume: 2,814,979
  • Market Cap: £8.26m
  • RiskGrade: 747

Latest ShareCast News

Genedrive upbeat on publication of clinical performance data

By Josh White

Date: Friday 27 Dec 2024

(Sharecast News) - Point-of-care pharmacogenetic testing specialist Genedrive announced on Friday that clinical performance data for its Genedrive CYP2C19-ID Kit had been published in the Journal of Molecular Biology.

Genedrive full-year revenue rises

By Josh White

Date: Friday 29 Nov 2024

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive reported a significant increase in revenue in its full-year results on Friday.

Director dealings: Genedrive chairman snaps up shares

By Iain Gilbert

Date: Thursday 15 Aug 2024

(Sharecast News) - Genedrive revealed on Thursday that chairman Ian Gilham had acquired 1.0m shares in the AIM-listed pharmacogenetic testing company.

Genedrive makes first commercial sales of CYP2C1... 12-Aug-2024 ShareCast
Genedrive test ordered by five Manchester area h... 24-May-2024 ShareCast
Genedrive shares jump on NICE test recommendation 03-Apr-2024 ShareCast
Genedrive receives R&D tax credit, plans fundraise 15-Mar-2024 ShareCast
Genedrive set to apply for NICE EVA funding 19-Feb-2024 ShareCast
Genedrive confirms £0.6m equity prepayment drawd... 02-Jan-2024 ShareCast
Genedrive gets first product orders from several... 20-Dec-2023 ShareCast
Genedrive diagnostic test system gets UKCA regis... 06-Sep-2023 ShareCast
Genedrive draws down £0.3m under equity prepayme... 05-Jul-2023 ShareCast
Genedrive secures multi-partner grant award 16-Jun-2023 ShareCast
Genedrive jumps on draft NICE testing guidance 19-May-2023 ShareCast
Genedrive engages with US FDA over infant test 05-Oct-2022 ShareCast
Genedrive test to go through new, faster NICE pr... 26-Sep-2022 ShareCast
Another Genedrive test to be assessed by NICE 22-Aug-2022 ShareCast
Genedrive test to be evaluated by NICE 16-Jun-2022 ShareCast
Genedrive rallies on positive news about hearing... 29-Mar-2022 ShareCast
Genedrive finance chief announces April departure 02-Mar-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 1.52p
Change Today -0.010p
% Change -0.65 %
52 Week High 7.80p
52 Week Low 1.45p
Volume 2,814,979
Shares Issued 543.14m
Market Cap £8.26m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.08% below the market average17.08% below the market average17.08% below the market average17.08% below the market average17.08% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Price Trend
79.55% below the market average79.55% below the market average79.55% below the market average79.55% below the market average79.55% below the market average
67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average
Income Not Available
Growth
68.75% above the market average68.75% above the market average68.75% above the market average68.75% above the market average68.75% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average

Genedrive Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
17:07 48,628 @ 1.52p
16:35 4,000 @ 1.52p
16:35 4,000 @ 1.52p
16:29 23,197 @ 1.50p
16:28 30,334 @ 1.50p

Genedrive Key Personnel

CFO Russell Shaw
CEO Gino Miele

Top of Page